|
|
|
| Take a tour of Nanoform's best-in-class nanodevelopment capabilities, setting new standards in innovation. Their highly specialized team excels in creating unique nanoparticles for both small and large molecule APIs. With 14 development lines for small molecules and 5 for large molecules, Nanoform offers unmatched scalability and precision. Leveraging cutting-edge technology, they produce nanoformed materials as small as 10 nanometers. Learn more |
|
|
|
|
By Drug Delivery Leader Editorial Staff | To mitigate inherent risks like inconsistent dosing, user error, and low adoption due to complex usage procedures, technological innovation in delivery devices is best guided by lessons from the past, including user feedback and follow-on learnings from market data. | |
|
|
Oral Peptides Deliver Bladder Dysfunction Therapies | By Drug Delivery Leader: Sit and Deliver | In this episode of Sit and Deliver, host Tom von Gunden talks with Chief Scientific Officer Karl Thor of Dignify Therapeutics about providing relief for patients suffering from neurogenic bowel and bladder dysfunction. |
|
|
|
| Streamlining Viral Gene Therapy Development | Article | By Tara Quang and Michael Baker, FUJIFILM Biotechnologies | Analytical technologies like Droplet Digital PCR (ddPCR) provide a more rapid approach to nucleic acid quantification for better sensitivity, accuracy, and precision in therapeutic development. |
|
|
|
| Low Temperature Storage Containment | Article | By Amy Rovi, West Pharmaceutical Services, Inc. | With the growth of advanced therapy medicinal products, there is an increased need for specialized packaging solutions, particularly for vials and syringe systems at -50°C to ≤ -130°C. |
|
|
|
| Overcoming A Failed Verification | Article | Stevanato Group | If a drug delivery device fails a design verification test, the consequences can be lost revenue for the pharma company and delays for patients. Learn how to eliminate design verification failure. |
|
|
|
|
|
|
|
.png){kind=logo}
